Locking of biochemical assays for digital microfluidic biochips

Abstract

It is expected that as digital microfluidic biochips (DMFBs) mature, the hardware design flow will begin to resemble the current practice in the semiconductor industry: design teams send chip layouts to third party foundries for fabrication. These foundries are untrusted, and threaten to steal valuable intellectual property (IP). In a DMFB, the IP consists of not only hardware layouts, but also of the biochemical assays (bioassays) that are intended to be executed on-chip. DMFB designers therefore must defend these protocols against theft. We propose to “lock” biochemical assays through random insertion of dummy mix-split operations, subject to several design rules. We experimentally evaluate the proposed locking mechanism, and show how a high level of protection can be achieved even on bioassays with low complexity. We offer guidance on the number of dummy mixsplits required to secure a bioassay for the lifetime of a patent.